<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024535" disease_type="Disease or Syndrome" abbrv="">Plasmodium falciparum malaria</z:e> (Pf-<z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e>) and Epstein Barr Virus (EBV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> coexist in children at risk for endemic Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (eBL); yet studies have only glimpsed the cumulative effect of Pf-<z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> on EBV-specific immunity </plain></SENT>
<SENT sid="1" pm="."><plain>Using pooled EBV lytic and latent CD8+ T-cell <z:chebi fb="0" ids="53000">epitope</z:chebi>-<z:chebi fb="7" ids="16670">peptides</z:chebi>, IFN-γ ELISPOT responses were surveyed three times among children (10 months to 15 years) in Kenya from 2002-2004 </plain></SENT>
<SENT sid="2" pm="."><plain>Prevalence ratios (PR) and 95% confidence intervals (CI) were estimated in association with Pf-<z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> exposure, defined at the district-level (Kisumu: holoendemic; Nandi: hypoendemic) and the individual-level </plain></SENT>
<SENT sid="3" pm="."><plain>We observed a 46% decrease in positive EBV lytic antigen IFN-γ responses among 5-9 year olds residing in Kisumu compared to Nandi (PR: 0.54; 95% CI: 0.30-0.99) </plain></SENT>
<SENT sid="4" pm="."><plain>Individual-level analysis in Kisumu revealed further impairment of EBV lytic antigen responses among 5-9 year olds consistently infected with Pf-<z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> compared to those never infected </plain></SENT>
<SENT sid="5" pm="."><plain>There were no observed district- or individual-level differences between Pf-<z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> exposure and EBV latent antigen IFN-γ response </plain></SENT>
<SENT sid="6" pm="."><plain>The gradual decrease of EBV lytic antigen but not latent antigen IFN-γ responses after <z:e sem="disease" ids="C0948192" disease_type="Disease or Syndrome" abbrv="">primary infection</z:e> suggests a specific loss in immunological control over the lytic cycle in children residing in <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> holoendemic areas, further refining our understanding of eBL etiology </plain></SENT>
</text></document>